As an internal grant funding program of the ICTS, the Clinical and Translational Research Funding Program (CTRFP) awards projects that promote the translation of scientific discoveries into improvement in human health. Annually, the CTRFP receives over 100 applications and awards approximately $1M for investigator-initiated projects. These projects are supported with funding from the ICTS and our partner institutions including The Foundation for Barnes-Jewish Hospital, Saint Louis University, and the University of Missouri-Columbia.

Awards will be considered for:

  • Clinical/Translational Projects whose goals are to promote the translation of scientific discoveries into human health. Awards in this category will provide up to $50,000 direct costs for 1 year.
  • Collaborative Projects that involve multidisciplinary groups of research teams from at least two ICTS partner institutions. Each investigator must have a defined role in the research project. A lead PI must be identified and a subcontract must be included for the collaborating institution. Awards in this category will provide up to $50,000 direct costs for 1 year.
    Matchmaker is a new extension of the NIH RePORTER system that makes it easy to find similar projects already funded by the NIH.
  • Community-Engaged Research Projects that involve established partnerships with communities and/or stakeholders whose health and well-being and/or service provision could be most impacted by the research. Awards in this category will provide up to $50,000 direct costs for 1 year.
  • Biostatistics, Epidemiology, and Research Design Projects Provide up to $25,000 for 1 year of seed funding to facilitate new innovative methodology development with clinical and translational science needs. (Note, this program has its own overview and application instructions packet.)

Additional consideration will be given to proposals that address the national opioid epidemic, including early stage translational research (improve understanding of pain, discovery and evaluation of innovative treatments) and late stage research (strategies to restrict opioid supply, influence prescribing practices, preventing addiction and overdose fatalities).


All Principal Investigators applying for this funding must be members of the ICTS. Member eligibility information and registration are available here.

The ICTS expects to issue an annual call for proposals with award types determined each year based on program priorities.

Angie Crawford – 314-362-7707
Jaimee Stagner – 314-362-6325